Home/Filings/4/0001562180-24-003439
4//SEC Filing

Humer Kristian 4

Accession 0001562180-24-003439

CIK 0001822462other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 4:01 PM ET

Size

5.7 KB

Accession

0001562180-24-003439

Insider Transaction Report

Form 4
Period: 2024-04-16
Humer Kristian
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2024-04-16$6.03/sh+275,000$1,658,250275,000 total
    Exercise: $6.03Exp: 2034-04-15Common Stock (275,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on April 16, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.

Issuer

Foghorn Therapeutics Inc.

CIK 0001822462

Entity typeother

Related Parties

1
  • filerCIK 0001872280

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:01 PM ET
Size
5.7 KB